Itau Unibanco Holding S.A.’s Novavax NVAX Stock Holding History

Itau Unibanco Holding S.A.’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-430	Closed	-$8K	–	602
2022 Q3	$8K	Sell	430 -4,524	-91%	-$196K	﹤0.01%	499
2022 Q2	$255K	Buy	4,954 +4,726	+2,073%	+$245K	0.01%	199
2022 Q1	$17K	Hold	228	–	–	﹤0.01%	396
2021 Q4	$35K	Buy	228 +51	+29%	+$8.76K	﹤0.01%	335
2021 Q3	$37K	Buy	177 +5	+3%	+$1.1K	﹤0.01%	293
2021 Q2	$37K	Buy	+172	New	+$31.5K	﹤0.01%	239

Other funds holding NVAX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

HIG

Herr Investment Group Austin, Texas $1.5B AUM 29.27% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Itau Unibanco Holding S.A.'s NVAX Position: Q4 2022 in Review

Itau Unibanco Holding S.A. sold out of Novavax (NVAX) in Q4 2022, closing a stake of 430 shares — an estimated $8K sold.

Itau Unibanco Holding S.A. first reported a position in NVAX in Q2 2021 and held it in 6 quarters. The position peaked at $255K in Q2 2022. 252 funds tracked by Wall St. Rank hold NVAX as of Q4 2022.

Itau Unibanco Holding S.A. reported no remaining Novavax position as of Q4 2022 after selling out during the quarter.
Itau Unibanco Holding S.A. sold 430 Novavax shares in Q4 2022, an estimated $8K.
Itau Unibanco Holding S.A. first reported a position in Novavax in Q2 2021 and held it in 6 quarters.
Itau Unibanco Holding S.A.'s Novavax position peaked at $255K in Q2 2022.
252 funds tracked by Wall St. Rank held Novavax as of Q4 2022.

Based on Itau Unibanco Holding S.A.'s 13F filing for Q4 2022, filed 9 Feb 2023.